(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 1.72% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.45%.
Baxter International's revenue in 2026 is $11,470,000,000.On average, 17 Wall Street analysts forecast BAX's revenue for 2026 to be $5,965,099,836,462, with the lowest BAX revenue forecast at $5,738,655,588,900, and the highest BAX revenue forecast at $6,321,310,079,773. On average, 17 Wall Street analysts forecast BAX's revenue for 2027 to be $6,081,423,936,237, with the lowest BAX revenue forecast at $5,837,401,824,709, and the highest BAX revenue forecast at $6,427,294,259,568.
In 2028, BAX is forecast to generate $6,257,202,575,897 in revenue, with the lowest revenue forecast at $5,968,201,812,456 and the highest revenue forecast at $6,623,235,743,189.